Milwaukee Journal Sentinel health and science reporter John Fauber reports that, “as universities tighten ethics policies, drug firms turn to private physicians to promote products.” He profiles one doctor who received $45,000 from GlaxoSmithKline during a three-month period for which records were released – up to $3,000 a talk for 15 talks in the three-month period, according to the drug company.
MedPageToday.com published another version of Fauber’s story, in the start of a new partnership between the online site and the Milwaukee paper. MPT says this will be the first of at least 10 this year in the partnership – to produce what they call “dig-deeper pieces — in-depth reports on topics that stretch beyond daily news to look at trends and critical issues.” The piece includes an almost 9-minute video interview Fauber conducted with Dr. George Lundberg, former editor of the Journal of the American Medical Association, who recently joined MedPageToday as editor-at-large.
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like